ATE57376T1 - Ortho-anisamide, verfahren zu deren herstellung und deren pharmazeutische anwendungen. - Google Patents
Ortho-anisamide, verfahren zu deren herstellung und deren pharmazeutische anwendungen.Info
- Publication number
- ATE57376T1 ATE57376T1 AT86402796T AT86402796T ATE57376T1 AT E57376 T1 ATE57376 T1 AT E57376T1 AT 86402796 T AT86402796 T AT 86402796T AT 86402796 T AT86402796 T AT 86402796T AT E57376 T1 ATE57376 T1 AT E57376T1
- Authority
- AT
- Austria
- Prior art keywords
- anisamides
- ortho
- processes
- production
- pharmaceutical applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8518829A FR2592042B1 (fr) | 1985-12-19 | 1985-12-19 | Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques |
EP86402796A EP0236646B1 (de) | 1985-12-19 | 1986-12-15 | Ortho-Anisamide, Verfahren zu deren Herstellung und deren pharmazeutische Anwendungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE57376T1 true ATE57376T1 (de) | 1990-10-15 |
Family
ID=9325965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT86402796T ATE57376T1 (de) | 1985-12-19 | 1986-12-15 | Ortho-anisamide, verfahren zu deren herstellung und deren pharmazeutische anwendungen. |
Country Status (37)
Country | Link |
---|---|
US (2) | US4835172A (de) |
EP (1) | EP0236646B1 (de) |
JP (1) | JPS62246553A (de) |
KR (1) | KR930004653B1 (de) |
CN (1) | CN1018454B (de) |
AR (1) | AR242193A1 (de) |
AT (1) | ATE57376T1 (de) |
AU (1) | AU586057B2 (de) |
CA (2) | CA1298301C (de) |
CH (1) | CH671396A5 (de) |
CS (1) | CS274285B2 (de) |
DD (1) | DD260495A5 (de) |
DE (2) | DE3674916D1 (de) |
DK (1) | DK612886A (de) |
ES (1) | ES2036178T3 (de) |
FI (1) | FI865190A (de) |
FR (1) | FR2592042B1 (de) |
GB (1) | GB2184723B (de) |
GR (1) | GR3002524T3 (de) |
HU (1) | HU196794B (de) |
IE (1) | IE59212B1 (de) |
IL (1) | IL81010A (de) |
IN (1) | IN163130B (de) |
IS (1) | IS1448B6 (de) |
MA (1) | MA20835A1 (de) |
NO (1) | NO168176C (de) |
NZ (1) | NZ218675A (de) |
OA (1) | OA08564A (de) |
PH (2) | PH24365A (de) |
PL (1) | PL148408B1 (de) |
PT (1) | PT83982B (de) |
SU (1) | SU1496632A3 (de) |
TN (1) | TNSN86165A1 (de) |
YU (1) | YU44796B (de) |
ZA (1) | ZA869560B (de) |
ZM (1) | ZM10686A1 (de) |
ZW (1) | ZW24886A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0295350B1 (de) * | 1987-06-17 | 1992-11-11 | Laboratoires DELAGRANGE | Anwendung von N-[2-(diäthylamino)äthyl]-2-methoxy-4[(1-H-4,5-dihydro-2-imidazolyl)amino]-5-chlorobenzamid als anxiolytisches und antipsychotisches Mittel |
FR2640139A1 (fr) * | 1988-12-14 | 1990-06-15 | Delagrange Laboratoires | Application de benzamides substitues comme gastromoteurs |
FR2640507A1 (fr) * | 1988-12-20 | 1990-06-22 | Delagrange Laboratoires | Application de benzamides substitues comme anxiolytiques et anti-psychotiques |
FR2645742A1 (fr) * | 1989-04-12 | 1990-10-19 | Delagrange Laboratoires | Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive |
US5401851A (en) * | 1992-06-03 | 1995-03-28 | Eli Lilly And Company | Angiotensin II antagonists |
US20050140688A1 (en) * | 2003-12-29 | 2005-06-30 | Kim Pallister | Method and mechanism for programmable filtering of texture map data in 3D graphics subsystems |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3342826A (en) * | 1964-01-13 | 1967-09-19 | Ile De France | Heterocyclic aminoalkyl benzamides |
FR1539104A (fr) * | 1967-07-31 | 1968-09-13 | Ile De France | Nouveaux benzamides et leur procédé de préparation |
US3682968A (en) * | 1969-06-25 | 1972-08-08 | Merck & Co Inc | Anti-inflammatory salicylic acid derivatives |
DE1963193A1 (de) * | 1969-12-17 | 1971-06-24 | Bayer Ag | N-substituierte 2-Arylimino-oxazolidine,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasiticide |
FR2432513A1 (fr) * | 1977-10-24 | 1980-02-29 | Merieux Inst | Nouveaux derives de la thiazoline et leur application comme medicaments |
DE2905883A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Sohn Ingelheim | Radioimmuntest fuer clonidin |
US4461904A (en) * | 1981-11-20 | 1984-07-24 | Alcon Laboratories, Inc. | 2-(Trisubstituted phenylimino)-imidazolines |
CA1201066A (en) * | 1981-11-20 | 1986-02-25 | Alcon Laboratories, Inc. | N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure |
DE3514351A1 (de) * | 1985-04-20 | 1986-11-06 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung |
JPS6341471A (ja) * | 1986-08-08 | 1988-02-22 | Nippon Soda Co Ltd | オキサ(チア)ゾリジン誘導体、その製造法及び殺ダニ剤 |
US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
-
1985
- 1985-12-19 FR FR8518829A patent/FR2592042B1/fr not_active Expired
-
1986
- 1986-12-15 AT AT86402796T patent/ATE57376T1/de active
- 1986-12-15 ES ES198686402796T patent/ES2036178T3/es not_active Expired - Lifetime
- 1986-12-15 DE DE8686402796T patent/DE3674916D1/de not_active Expired - Lifetime
- 1986-12-15 IE IE327086A patent/IE59212B1/en not_active IP Right Cessation
- 1986-12-15 EP EP86402796A patent/EP0236646B1/de not_active Expired - Lifetime
- 1986-12-16 IN IN983/MAS/86A patent/IN163130B/en unknown
- 1986-12-16 CH CH4997/86A patent/CH671396A5/fr not_active IP Right Cessation
- 1986-12-17 IL IL81010A patent/IL81010A/xx not_active IP Right Cessation
- 1986-12-17 DE DE19863643103 patent/DE3643103A1/de not_active Withdrawn
- 1986-12-17 MA MA21067A patent/MA20835A1/fr unknown
- 1986-12-17 AR AR86306202A patent/AR242193A1/es active
- 1986-12-17 PH PH34606A patent/PH24365A/en unknown
- 1986-12-17 GB GB8630143A patent/GB2184723B/en not_active Expired
- 1986-12-17 HU HU865271A patent/HU196794B/hu not_active IP Right Cessation
- 1986-12-17 NZ NZ218675A patent/NZ218675A/xx unknown
- 1986-12-17 IS IS3178A patent/IS1448B6/is unknown
- 1986-12-17 DD DD86297795A patent/DD260495A5/de not_active IP Right Cessation
- 1986-12-18 CA CA000525719A patent/CA1298301C/fr not_active Expired - Lifetime
- 1986-12-18 SU SU864028722A patent/SU1496632A3/ru active
- 1986-12-18 YU YU2179/86A patent/YU44796B/xx unknown
- 1986-12-18 FI FI865190A patent/FI865190A/fi not_active Application Discontinuation
- 1986-12-18 OA OA59022A patent/OA08564A/xx unknown
- 1986-12-18 AU AU66687/86A patent/AU586057B2/en not_active Ceased
- 1986-12-18 CN CN86108972A patent/CN1018454B/zh not_active Expired
- 1986-12-18 PL PL1986263078A patent/PL148408B1/pl unknown
- 1986-12-18 KR KR1019860010868A patent/KR930004653B1/ko not_active IP Right Cessation
- 1986-12-18 DK DK612886A patent/DK612886A/da not_active Application Discontinuation
- 1986-12-18 ZM ZM106/86A patent/ZM10686A1/xx unknown
- 1986-12-18 NO NO865148A patent/NO168176C/no unknown
- 1986-12-19 CS CS960386A patent/CS274285B2/cs unknown
- 1986-12-19 ZW ZW248/86A patent/ZW24886A1/xx unknown
- 1986-12-19 JP JP61305136A patent/JPS62246553A/ja active Pending
- 1986-12-19 TN TNTNSN86165A patent/TNSN86165A1/fr unknown
- 1986-12-19 US US06/943,708 patent/US4835172A/en not_active Expired - Fee Related
- 1986-12-19 ZA ZA869560A patent/ZA869560B/xx unknown
- 1986-12-19 PT PT83982A patent/PT83982B/pt not_active IP Right Cessation
-
1988
- 1988-02-17 PH PH36522A patent/PH24469A/en unknown
-
1989
- 1989-03-13 US US07/322,122 patent/US4914117A/en not_active Expired - Fee Related
-
1990
- 1990-10-22 CA CA000615908A patent/CA1299579C/fr not_active Expired - Lifetime
- 1990-11-13 GR GR90400910T patent/GR3002524T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3781195D1 (de) | Substituierte benzamidderivate, verfahren zu deren herstellung und diese enthaltende medikamente. | |
ATE111452T1 (de) | Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate. | |
ATE46900T1 (de) | Phenylethanolaminotetraline, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3582576D1 (de) | Dithioketo-pyrrolo-pyrrole, verfahren zu deren herstellung und verwendung. | |
DE3680877D1 (de) | Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3667259D1 (de) | Orientierte elastomerfolie und verfahren zu deren herstellung. | |
DE68920061D1 (de) | Hydrofile, feine Gelpartikel und Verfahren zu deren Herstellung. | |
DE3686597D1 (de) | Uricase und verfahren zu deren herstellung. | |
DE3777122D1 (de) | Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3687021D1 (de) | Pyridazinonderivate, verfahren zu deren herstellung und insekttoetende zusammenstellungen. | |
DE3676002D1 (de) | Quaternaere oxalkylierte polykondensate, verfahren zu deren herstellung und deren verwendung. | |
DE3673763D1 (de) | Elektrostatisch hergestellte strukturen und verfahren zu deren herstellung. | |
DE3686561D1 (de) | Klebstrukturen und verfahren zu deren herstellung. | |
DE3675714D1 (de) | Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3683249D1 (de) | 2-aminosulfonyl-6-nitrobenzoesaeureester oder amide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3766299D1 (de) | 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
DE3672030D1 (de) | Halbleitervorrichtung und methode zu deren herstellung. | |
DE3681334D1 (de) | Androstane-17-beta-carbonsaeureester, verfahren zu deren herstellung und pharmazeutische praeparate die diese enthalten. | |
DE3767894D1 (de) | 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
ATE57376T1 (de) | Ortho-anisamide, verfahren zu deren herstellung und deren pharmazeutische anwendungen. | |
DE58904595D1 (de) | Neue alkylphosphonoserine, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel. | |
DE3583780D1 (de) | 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3670638D1 (de) | Indol-3-yl-chinazolin-1,4-benzodiazepin-5,13-dione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
DE3679739D1 (de) | Dekorative fassung und verfahren zu deren herstellung. | |
DE3670635D1 (de) | Neue benzisoselenazolonyl-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. |